Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the phase III OlympiA trial, 1 year of adjuvant therapy with olaparib significantly improved disease-free survival compared with placebo in patients with early -stage, high-risk, BRCA-mutated, HER2-negative breast cancer, suggesting a new standard of care.…